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Summary  We  report  a  case  of  a  22-year-old  woman  affected  by  catecholaminergic  poly-
morphic  ventricular  tachycardia  admitted  to  our  hospital  following  multiple  appropriate
inefﬁcacious  deﬁbrillator  shocks.  Left  cardiac  sympathetic  denervation  is  proposed  as  a  viableventricular
tachycardia;
Left  cardiac
sympathetic
denervation;
therapeutic  option  to  solve  such  a  delicate  case  history.
©  2011  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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atecholaminergic  polymorphic  ventricular  tachycardia
CPVT) is  a  well-known  cardiac  disease  associated  with
n increased  risk  of  sudden  cardiac  death,  affecting
ainly young  individuals  by  age  20—30  years  [1].  Muta-ions in  the  cardiac  ryanodine  receptor  [2]  and  in  the
alsequestrin protein  [3],  both  of  which  play  a  key  role
n calcium  trafﬁcking  from  the  sarcoplasmic  reticulum
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oi:10.1016/j.jccase.2011.05.003nto  the  cytosol,  lead  to  a  pathological  intracellular  cal-
ium overload.  Under  sympathetic  stimulation,  delayed
fterdepolarizations and  triggered  activity  may  occur
nd cause  ventricular  arrhythmias.  Beta-blockers  are  the
rst-choice therapy.  Implantable  cardioverter-deﬁbrillators
ICD) are  usually  indicated  in  patients  refractory  to
harmacological therapy.  Nevertheless,  in  patients  with
ultiple arrhythmic  episodes  and  consequent  device
hocks, left  cardiac  sympathetic  denervation  (LCSD)  is
 viable  therapeutic  option,  being  able  to  reduce  nore-
inephrine release  in  the  heart  and  thus  attenuating  the
drenergic triggers  that  precipitate  malignant  ventricular
rrhythmias.
 Published by Elsevier Ltd. All rights reserved.
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rFigure  1  12-lead  electrocardiogram  
We  present  a  case  of  a  young  woman  affected  by  CPVT
who underwent  LCSD  after  several  inefﬁcacious  ICD  shocks
on episodes  of  polymorphic  ventricular  tachycardia.Case history
A  22-year-old  woman  affected  by  CPVT  presented  to  our
outpatient clinic  after  recurrent  pre-syncopal  episodes
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Figure  2  An  episode  of  polymorphic  ventricular  tachycardia  (PVT
(ICD) discharges  at  maximum  output.  Top  channel  shows  ‘near-ﬁeld’
to  RV  coil)  ventricular  electrograms  whereas  the  bottom  channel  di
asterisks)  a  few  episodes  of  ventricular  undersensing  during  PVT  th
this  arrhythmia.e  patient  at  the  time  of  the  diagnosis.
ssociated  with  sweating  and  irregular  fast  palpitations.
oncomitantly to  these  episodes,  she  had  received  sev-
ral ICD  shocks.  The  clinical  examination  and  resting
2-lead electrocardiogram  (ECG)  were  unremarkable.  Her
esting heart  rate  was  70  beats/min.  The  patient  was
nder a  combination  therapy  of  propranolol  and  vera-
amil.
Three years  before  the  present  clinical  evaluation,
he patient  received  a  single  chamber  ICD,  after  an
)  which  caused  multiple  implantable  cardioverter-deﬁbrillator
 (RVtip  to  RVring);  intermediate  channel  shows  ‘far-ﬁeld’  (can
splays  ICD  markers  and  beat-to-beat  cycle  length.  Note  (black
at  can  limit  efﬁcacy  of  the  ICD  in  preventing  sudden  death  in
e36  A.  Sorgente  et  al.
Figure  3  Report  of  the  interrogation  of  the  implantable  cardioverter-deﬁbrillator  after  2  months  from  left  cardiac  sympathetic
denervation.  Noteworthy  is  the  absence  of  new  ventricular  events,  the  increase  of  heart  rate  variability  and  the  decrease  of  the
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dverage  heart  rate.  VT/VF,  ventricular  tachycardia/ventricular  
pisode  of  resuscitated  polymorphic  ventricular  tachy-
ardia/ventricular ﬁbrillation.  At  that  time,  the  clinical
iagnosis of  CPVT  was  supported  by  the  absence  of  any
bnormal ﬁnding  on  cardiac  magnetic  resonance  imag-
ng. There  was  normal  epicardial  fat  distribution,  the
yocardium appeared  to  have  homogenous  signal  inten-
ity, and  there  were  no  pericardial  or  pleural  effusions.  The
rigins of  the  left  main  and  right  coronary  arteries  were
dentiﬁed in  their  customary  positions.  The  indexed  diam-
ters of  the  ascending  and  descending  thoracic  aorta  were
ormal. The  main  pulmonary  artery  diameter  index  was
ormal. The  left  ventricular  end-diastolic  dimension  index
as normal  as  well  as  the  end-diastolic  volume  index.  The
alculated left  ventricular  ejection  fraction  was  normal  at
0% with  normal  regional  systolic  function.  The  anterosep-
al and  inferolateral  wall  thicknesses  were  normal.  The  left
entricular mass  index  was  normal.  The  right  ventricular
nd-diastolic volume  index  was  normal.  The  calculated  right
entricular ejection  fraction  was  normal  at  68%,  with  normal
u
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ree  wall  motion.  An  ECG  recorded  concomitantly  is  shown
n Fig.  1.
About 2  years  after  the  implantation,  the  patient  had
lready experienced  2  internal  shocks  on  another  episode
f short-lasting  prolonged  polymorphic  ventricular  tachy-
ardia. At  that  time,  a  re-programmation  of  the  ICD  was
erformed (VF  detection  zone  was  increased  to  >231  bpm
nd time  of  conﬁrmation  was  extended  from  2.5  to  5  s)
ogether with  a  titration  of  beta-blockers  to  maximum
olerable doses  (propranolol  was  increased  from  30  mg  to
0 mg/day).
The  most  interesting  part  of  the  present  interrogation  of
he ICD  is  shown  in  Fig.  2.  A  polymorphic  ventricular  tachy-
ardia with  a  variable  cycle  length  (range  240—360  ms)  was
etected by  the  device  and  recognized  ﬁrstly  as  ventric-
lar tachycardia  and  afterwards  as  ventricular  ﬁbrillation.
nterestingly, a  beat-to-beat  180◦ rotation  of  the  major  axis
f the  ventricular  electrograms  was  noted  and  occasionally
ssociated with  ventricular  undersensing  (black  asterisks  in
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[CPVT  and  left  cardiac  sympathetic  denervation  
Fig.  2).  An  attempt  of  internal  deﬁbrillation  was  performed
by the  device  without  restoration  of  sinus  rhythm.  Finally,
the tachycardia  spontaneously  slowed  and  then  terminated.
A  decision  to  perform  a  LCSD  was  taken.  After  creation
of a  left-sided  pneumothorax  with  a  Küss-needle  under
general anesthesia,  the  thoracoscope  (R.  Wolf,  Knitlingen,
Germany) (7  mm  trocar),  and  the  coagulation  forceps  (5  mm
trocar) were  introduced  via  the  second  intercostal  space
(10 mm  trocar)  into  the  thoracic  cavity  to  identify  and
lyse the  T2,  T3,  and  T4  sympathetic  ganglia.  Then  the
pneumothorax was  reduced  and  the  skin  closed  without
leaving a  chest  drain.  The  procedure  had  no  complications.
A dramatic  reduction  in  shock  therapies  and  an  increase
in heart  rate  variability  associated  with  a  marked  improve-
ment in  the  quality  of  life  was  veriﬁed  at  the  2  months
(Fig. 3)  and  at  12  months  follow-up.
Discussion
As  already  demonstrated  elsewhere,  our  case  report  high-
lights the  clinical  beneﬁt  deriving  from  LCSD  in  patients
with CPVT  refractory  to  pharmacological  therapy  and  hav-
ing already  undergone  an  implantation  of  an  ICD.  Another
important issue  raised  by  the  present  report  is  the  potential
risk of  inefﬁcacy  of  DC  shocks  in  patients  with  refractory
CPVT and  of  transient  ventricular  undersensing  during  malig-
nant ventricular  arrhythmias.
Current  clinical  guidelines  advise  implantation  of  an  ICD
in all  patients  with  drug-refractory  CPVT.  Given  the  nature  of
CPVT, appropriate  ICD  shocks  are  potentially  lifesaving  but
can  also  cause  pain  and  fear.  Both  result  in  the  release  of  cat-
echolamines, which  can  favor  a  new  episode  of  ventricular
tachycardia or  ventricular  ﬁbrillation  and  a  second  shock,
potentially inducing  a  vicious  cycle  and  cause  arrhythmic
storms. In  this  clinical  context,  LCSD  can  be  a  reasonable
alternative and  has  demonstrated  in  a  very  selected  popu-
lation good  clinical  results.  LCSD  blocks  the  major  source  of
norepinephrine released  in  the  heart  and  has  several  antiar-
rhythmic effects,  including  an  increase  in  the  threshold  for
ventricular ﬁbrillation  and  an  increase  in  ventricular  refrac-
toriness [4—6].  Furthermore,  since  LCSD  is  a  preganglionic
denervation, there  is  no  potential  reinnervation  and  no  post-
denervation supersensitivity,  since  catecholamines  continue
to be  present  in  the  ventricles  after  surgical  removal  of  the
ganglions [7].  A  major  advantage  of  the  denervation  is  that
its effect  is  permanent  and  this  feature  can  help  to  over-
come the  possible  lack  of  compliance  in  young  individuals
affected by  CPVT.  In  our  case,  LCSD  cancelled  the  arrhythmic
burden and  improved  the  quality  of  life  of  the  patient.
[e37
Polymorphic ventricular  tachycardias  are  characterized
y unpredictable  occurrence  and  by  a  trend  to  cluster  [8].
CD is  indicated  for  those  patients  who  continue  to  develop
entricular arrhythmias  during  exercise  even  under  beta-
lockers. Unfortunately,  it  cannot  be  considered  the  ideal
olution, especially  when  DC  shocks  could  trigger  ventricu-
ar arrhythmias  [7]  or,  like  it  happened  in  our  patient,  when  a
ransient ventricular  oversensing  occurred,  potentially  lim-
ting the  capacity  of  the  ICD  of  recognizing  a  malignant
entricular tachycardia.
Currently,  there  is  no  universally  acceptable  strategy  to
anage recurrent  CPVT  refractory  to  both  medical  therapy
nd to  internal  deﬁbrillation.  We  propose  LSCD  as  a  useful
herapeutic tool  in  those  cases  of  malignant  drug  refractory
PVT and  raise  the  need  of  randomized  clinical  trials  on  the
opic to  conﬁrm  the  ﬁnding  of  our  clinical  case.
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